soul trial oral semaglutide cardiovascular outcomes 2024 nejm results reduced the risk of clinically important kidney and death from (CV) causes in patients with type 2 diabetes (T2D) and CKD ca. #ERA24 πΈπͺ #Nephpearls https://www.nejm .org/doi/full/10.1056/NEJMoa2403347 FLOWing with the SemagluTIDE β
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 12 - Aug 17





















![Regrowth [Foreign Black Border] PokΓ©mon GO](https://cdn.shopify.com/s/files/1/0745/6761/4772/products/4439ad4d-ff10-58ae-a333-ea97484a4675.jpg?v=1683349186)

![Kormus Bell [International Collectors' Edition] Moonfolk Monk](https://cdn.shopify.com/s/files/1/0745/6761/4772/products/dd54b620-894b-56fd-bfe2-33fd4f46e74b.jpg?v=1683348600)


